Healthcare >> CEO Interviews >> May 29, 2000
NORMAN J.W. RUSSELL, PhD, joined Lynx in July 1999 as President and
Chief Executive Officer. Prior to that he was Head of Biological Science
and Technology at AstraZeneca Pharmaceuticals. His previous positions in
20 years at Zeneca included Head of Target Discovery, Head of
International Genomics, and Head of Biotechnology. Dr. Russell gained
his PhD from Glasgow University, Scotland in 1977. Profile
just to set the stage for readers?
Dr. Russell: Lynx is a leader in developing and applying novel
technologies for the
